Designing Decellularized Extracellular Matrix-Based Bioinks for 3D Bioprinting

Adv Healthc Mater. 2020 Dec;9(24):e2000734. doi: 10.1002/adhm.202000734. Epub 2020 Jul 21.

Abstract

3D bioprinting is an emerging technology to fabricate tissues and organs by precisely positioning cells into 3D structures using printable cell-laden formulations known as bioinks. Various bioinks are utilized in 3D bioprinting applications; however, developing the perfect bioink to fabricate constructs with biomimetic microenvironment and mechanical properties that are similar to native tissues is a challenging task. In recent years, decellularized extracellular matrix (dECM)-based bioinks have received an increasing attention in 3D bioprinting applications, since they are derived from native tissues and possess unique, complex tissue-specific biochemical properties. This review focuses on designing dECM-based bioinks for tissue and organ bioprinting, including commonly used decellularization and decellularized tissue characterization methods, bioink formulation and characterization, applications of dECM-based bioinks, and most recent advancements in dECM-based bioink design.

Keywords: additive manufacturing; biofabrication; decellularization; tissue engineering.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Bioprinting*
  • Extracellular Matrix
  • Printing, Three-Dimensional
  • Tissue Engineering
  • Tissue Scaffolds